<DOC>
	<DOCNO>NCT00870857</DOCNO>
	<brief_summary>Despite availability highly active antiretroviral therapy ( HAART ) , lung disease remain leading cause morbidity mortality HIV infection . There large-scale study detail pulmonary complication HAART era . Substantial gap exist knowledge spectrum pathogenesis pulmonary disorder population , particularly woman minority whose number HIV AIDS increase . The Multicenter AIDS Cohort Study ( MACS ) Women 's Interagency Health Study ( WIHS ) prospective , multi-center cohort follow approximately 5000 HIV+ subject HIV- control . Although pulmonary disease area focus , establish cohort provide unique opportunity systematically study pulmonary complication HIV infection . Emphysema particular interest current HIV era likely increase population live long chronic HIV . HIV-infected person increase incidence emphysema compare without HIV infection , hypothesize accelerated disease progression result one latent infectious agent amplify pulmonary inflammation . Accelerated emphysema describe HIV infection predominantly male population HAART . The current prevalence characteristic HIV-associated emphysema , potential impact gender , rigorously define .</brief_summary>
	<brief_title>Prevalence Pathogenesis Lung Disease Large HIV Cohort-coordinating Center</brief_title>
	<detailed_description>HIV-infected patient increase incidence emphysema compare non-HIV-infected patient , hypothesize accelerated disease progression result one latent infection amplifies pulmonary inflammatory response . We examine prevalence progression emphysema subject without HIV determine risk factor emphysema population . Subjects 300 HIV+ subject 300 HIV- control select random sample stratified age smoke history . Subjects recruit University Pittsburgh University California Los Angles ( UCLA ) MACS sit . The University California San Francisco ( UCSF ) serve recruit center WIHS cohort . Because interested unbiased estimate extent disease HIV infection , select subject base lung function current diagnosis COPD . The HIV- subject match HIV+ subject term age smoke history extent possible . Those symptom acute respiratory disease fever , acute change cough shortness breath , weight loss exclude . There exclusion base HAART use opportunistic infection ( OI ) prophylaxis exclusion base previous lung disease try obtain comprehensive evaluation emphysema population well identify associate risk factor . All subject undergo spirometry , diffuse capacity quantitative CT scanning . These measurement allow u determine difference prevalence emphysema HIV+ HIV- determine risk factor associate emphysema . For longitudinal study test hypothesis emphysema accelerate HIV infection , select HIV+ HIV- subject document emphysema group define diffuse capacity &lt; 80 % predict , post-bronchodilator FEV1/FVC &lt; 70 % without significant reversibility , least 10 % lung density less -910 Hounsfield unit ( HU ) . These subject CT scan PFTs baseline 18 month 36 month baseline . At visit , clinical data biological sample collect .</detailed_description>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Emphysema</mesh_term>
	<mesh_term>Pneumonia , Pneumocystis</mesh_term>
	<criteria>Subject Male / Female 18years age old . Subject previously determine HIVinfected participate The Multicenter AIDS Cohort Study ( MACS ) Women 's Interagency Health Study ( WIHS ) Subject experience acute onset shortness breath , cough , fever heart condition problem tachycardia , angina arrhythmia . Female subject tell u pregnant ( might affect pulmonary function value , require pregnancy test . ) Subject MI , CVA , cardiovascular event within past 3 month . Subject eye abdominal surgery within past 3 month . Active TB documentation self report exclusion criterion study . Subjects exclude study unable sign consent , weigh &gt; 300 pound due technical difficulty CT/EBCT scanner , expose approximately 10 rad previous 12 month ( i.e. , 2 diagnostic CT scan 4 cardiac caths fluoroscopic exam ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Lungs</keyword>
	<keyword>antiretrovirals</keyword>
	<keyword>HIV</keyword>
	<keyword>COPD</keyword>
</DOC>